Key facts
- Take it once a day, preferably in the evening, with or without food, and follow the low-fat diet your doctor advises.
- Do not take it if you have liver disease, or if you are pregnant, trying to become pregnant or breast-feeding.
- Your doctor should do a blood test to check your liver before you start, and may repeat tests while you take it.
- Contact your doctor immediately if you get unexplained muscle ache, weakness, cramps or tenderness, especially with tiredness, fever or red-brown urine.
- If you stop taking it, your cholesterol levels may increase again.
Who should not take pravastatin
The leaflet says not to take it if any of these apply to you.
- if you are allergic to pravastatin or any of the other ingredients
- if you have liver disease, or if liver function tests keep showing excessive values without any identifiable reason
- if you are pregnant, trying to become pregnant or breast-feeding
Check with a doctor or pharmacist first
Tell them before you take it if any of these apply to you.
- if you have or have had myasthenia (general muscle weakness) or ocular myasthenia (eye muscle weakness), as statins may sometimes make it worse or cause it
- if you have kidney disease or a history of liver disease
- if you regularly drink large amounts of alcohol
- if you have a low function of your thyroid gland
- if you are taking other medicines (e.g. fibrates) to lower fatty substances in your blood
- if you had muscle problems during previous treatment to lower blood fats, or you or anyone in your family has a hereditary muscle disease, especially if you are over 65
Show 6 moreShow fewer
- if you are taking, or have taken in the last 7 days, fusidic acid (orally or by injection), as this can lead to serious muscle problems (rhabdomyolysis)
- if you have severe respiratory failure
- if you have diabetes or are at risk of developing diabetes, as your doctor will monitor you closely
- if you have constant muscle weakness
- blood tests may be needed before and possibly during treatment to assess your risk of muscle-related side effects, and you may also need this if you are 70 or older
- not recommended for children younger than 8 years old
How to take pravastatin
- Take once a day, preferably in the evening, with or without food, and swallow the tablets with a glass of water or other sufficient liquid.
- Usual doses: 10-40 mg once a day for high cholesterol (maximum 40 mg a day), 40 mg once a day to prevent heart and vessel disease, and 20 mg once a day after a transplant (can be adjusted up to 40 mg). Your doctor will tell you how much to take.
- Follow the low-fat diet your doctor advises for the full treatment period.
- The 20 mg and 40 mg tablets can be divided into equal doses.
- If you miss a dose, take your normal dose when it is next due and do not take a double dose.
Side effects
Get medical help straight away
The leaflet says to get help urgently, or to stop the medicine and speak to a doctor, if you notice any of these. In an emergency call 999.
- serious allergic reaction causing swelling of the face, lips, throat, tongue and excessive fluid in the body, with difficulty swallowing or breathing (angioedema, anaphylaxis) (very rare)
- skin rash, possibly with pain in the joints (Lupus erythematous-like syndrome) (very rare)
- destruction of muscle fibres (rhabdomyolysis), which may be associated with acute kidney failure, and inflammation of the muscles (myositis/polymyositis), causing aching, tender or weak muscles, decreased or dark coloured urine (very rare)
- serious liver problems including yellowing of the skin and/or eyes (jaundice), liver inflammation (hepatitis) and sudden rapid destruction of liver tissue (fulminant hepatic necrosis), which may cause feeling or being sick, loss of appetite, fever, itchy skin, dark urine, pale stools (very rare)
- inflammation of the pancreas causing moderate to severe stomach pain that spreads to the back (pancreatitis) (very rare)
- burning, tingling, numbness or pins and needles (paresthesia), which may be a sign of nerve damage (peripheral polyneuropathy) (very rare)
Show 1 moreShow fewer
- inflammation of the muscles and the skin (dermatomyositis) (very rare)
How common each side effect is
Grouped the way the leaflet groups them. Most people get none, or only a few. Each figure is the most that are affected, so "up to 1 in 10" can mean far fewer.
Common
Up to 1 in 10 people
- painful joints (arthralgia)
- increased production of liver enzymes seen in a blood test
Uncommon
Up to 1 in 100 people
- dizziness
- headache
- sleep disturbances
- difficulty sleeping
- problems with eyesight
- blurred vision
- double vision
- digestive problems or slow digestion
- indigestion/heartburn
- abdominal pain
Show 12 moreShow fewer
- feeling/being sick
- difficulty or delay emptying bowels
- diarrhoea
- wind
- itching
- rash
- hives
- scalp and hair problems (inclusive of hair loss)
- abnormal urination, e.g. pain, frequency, frequent urination at night
- problems with sexual functions
- tiredness
- inflamed tendons, sometimes associated with tearing
Rare
Up to 1 in 1,000 people
- increased sensitivity to light (photosensitivity)
Very rare
Up to 1 in 10,000 people
- serious allergic reaction (angioedema, anaphylaxis)
- skin rash, possibly with pain in the joints (Lupus erythematous-like syndrome)
- destruction of muscle fibres (rhabdomyolysis), which may be associated with acute kidney failure
- inflammation of the muscles/many muscles (myositis/polymyositis)
- increased creatinine kinase seen in a blood test
- presence of myoglobin in the urine (myoglobinuria)
- serious liver problems including yellowish discoloration of the skin and/or eyes (jaundice)
- liver inflammation (hepatitis)
- sudden rapid destruction of liver tissue (fulminant hepatic necrosis)
- inflammation of the pancreas (pancreatitis)
Show 3 moreShow fewer
- problems with touch including burning/tingling sensation, numbness or pins and needles (paresthesia)
- damage to the nerve endings (peripheral polyneuropathy)
- inflammation of the muscles and the skin (dermatomyositis)
Not known
The leaflet says how often is not known
- diabetes
- breathing problems including persistent cough with shortness of breath and/or fever (interstitial lung disease)
- muscle weakness that is constant (Immune-mediated necrotising myopathy)
- myasthenia gravis
- ocular myasthenia
- muscle strains, tears and rupture
- nightmares
- memory loss
- depression
If you get a side effect, you can report it to the regulator through the Yellow Card scheme.
Pregnancy and breastfeeding
Do not take Pravastatin Sodium during pregnancy or while breast-feeding, as it may harm your baby. If you become pregnant during treatment, stop taking it and consult your doctor, and women who could become pregnant should use a reliable contraceptive.
Taking it with other medicines
The leaflet says to tell your doctor or pharmacist if you take any of these. This list is not checked against the medicines you take.
- any other medicines, including medicines obtained without a prescription
- fibrates (e.g. gemfibrozil and fenofibrate) or nicotinic acid
- colestyramine and colestipol
- ciclosporin
- antibiotics such as erythromycin, clarithromycin, roxithromycin and rifampicin
- fusidic acid (oral; you will need to temporarily stop Pravastatin Sodium)
- vitamin K antagonists (medicines used to treat and prevent blood clots)
- colchicine (used to treat gout)
- lenalidomide (used to treat multiple myeloma)
Where this comes from
Everything on this page is taken from one official document: the patient information leaflet that the UK medicines regulator (MHRA) approved for this product. Pestle reorganises it and puts it in plainer words. It adds nothing from anywhere else and does not rate medicines.
- Product
- Pravastatin Sodium 20mg Tablets
- Product licence
- PL 04569/1219
- Leaflet dated
- Checked against the leaflet
- Automated check
- 47 of 47 side effects matched to the wording of the leaflet
Other makers of pravastatin publish their own leaflets, which can differ slightly. Always read the leaflet that came with your medicine.
Read the official leaflet Original on the MHRA site How we make these pages